<DOC>
	<DOC>NCT01713127</DOC>
	<brief_summary>The purpose of this study is to evaluate efficacy of remifentanil in preterm infants during ventilator care with remifentanil and to analyze pharmacokinetics in preterm infants</brief_summary>
	<brief_title>Remifentanil in Ventilated Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>preterm infants (&lt;37weeks of gestational age) requiring ventilator care informed consent major anomaly 48hrs after birth requiring operation during drug infusion cord blood pH &lt; 7.0 intraventricular hemorrhage grade III or more investigators decision</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>